Bonnie G Coffa

Bonnie is the Business Development Manager at Enthalpy Analytical, LLC. Her background is in regulatory toxicology and has extensive experience managing in vitro toxicology studies for ENDS products, supporting nonclinical sections of FDA PMTA ENDS submissions and conducting toxicological evaluations of ingredients in tobacco, nicotine and cannabis products. Bonnie received her BS in biology from Texas State University, and PhD in pharmacology from Vanderbilt University. She completed a postdoctoral training in tobacco regulatory science at Altria Client Services, and was hired on as a research scientist in 2014 and later as Principal Scientist until 2019. Prior to joining Enthalpy, she was the principal toxicologist and founder of ToxPharm LLC, a regulatory toxicology consulting company created in 2019.

Enthalpy is the largest independent tobacco, smoke and e-vapor testing lab in the U.S. offering regulatory and research services to commercial, governmental, academic and regulatory agencies since 2000. We are an International Organization for Standardization (ISO)-17025 accredited lab offering comprehensive and exhaustive analysis of cigarette smoke, filler, smokeless tobacco, e-liquid, e-vapor, in vitro toxicology and product stability testing.  Enthalpy operates three smoke labs capable of e-vapor sample collection between its Richmond and Durham laboratories, allowing for redundancy and flexibility in our testing processes.  Enthalpy offers analysis and testing of e-vapor and e-liquids for the presence of nicotine, propylene glycol, glycerin, carbonyls (i.e., diacetyl, formaldehyde, etc.), particle sizing, and the FDA list of HPHCs. Enthalpy has analytical methods in place to meet requirements of the 2019 FDA Final Guidance for Premarket Tobacco Product Applications for Electronic Nicotine Delivery Systems (ENDS) Regulations and European Union Tobacco Product Directive (EU-TPD).